Shilpa Medicare-Zydus Lifesciences JV Secures USFDA Approval
Shilpa Medicare, in partnership with the Zydus Group through their joint venture Oncosol, and its collaborator Shorla Oncology, announced on November 27 that the USFDA...
Tag : Shilpa Medicare
Shilpa Medicare Secures API Approval from European Regulator
Shilpa Medicare on Tuesday, 19 November, announced receiving a suitability certificate for its active pharmaceutical ingredient (API), Octreotide, from a European regulatory authority. In its...
Shilpa Medicare Shares Rally 3% as Arm Secures CEP for Desmopressin
Shares of Shilpa Medicare Ltd were trading in the green and 3% higher on 4 October after the company announced that its subsidiary, Shilpa Pharma...
Shilpa Medicare Shares Skyrocketed 11% Successful Phase 3 Clinical Trial
The shares of Shilpa Medicare Ltd skyrocketed 11% on 26 August following the company’s announcement of a positive result in Phase 3 trials for SMLNUD07,...
Shilpa Medicare Bio-Analytical Laboratory Cleared with Zero Observations
Shilpa Medicare, on Tuesday, 25 June, announced that the US Food and Drug Administration (FDA) has successfully concluded an inspection of the company’s Bio-Analytical Laboratory,...
Shilpa Medicare Shares Gain 3% on Acquiring Pilnova Pharma
Shares of Shilpa Medicare were trading 3% higher on 3 November after the company announced acquiring United States-based Pilnova Pharma, which has now become the...
Shilpa Medicare Shares Rally on Approval From UK Regulator to Market Vertigo Drug
Shilpa Medicare announced on 4 September that it had received approval from the UK healthcare products regulator to market a Meniere’s syndrome drug. The company...
Shilpa Medicare Shares Fall 5% on Disappointing March Quarter Results
Shares of Shilpa Medicare fell 5% in early trading on May 26, as the drugmaker reported disappointing earnings for Q3FY22-23. The drugmaker posted a net...
Shilpa Medicare Shares Soar 9% as USFDA Approves To Psoriatic Arthritis Drug
The Shilpa Medicare share price mounted 9% in the opening trade on Tuesday soon after the company acknowledged the final approval for its Apremilast tablets...
Adani Wilmar, Varun Beverages to be Included in Nifty Next 50
As part of the semi-annual review of the National Stock Exchange’s broader market index, Adani Wilmar, Varun Beverages, Canara Bank, Page Industries, and ABB India...